In Canada and across the world, microbes that cause infections are becoming increasingly resistant to the drugs designed to treat them.
Antimicrobial resistance (AMR) is a top ten public health threat facing humanity and a leading cause of death worldwide.
Canada’s Honourable Mark Holland, Minister of Heath, has announced funding of up to $843,225 over three years to support the development and dissemination of national antimicrobial prescribing guidelines for 25 different syndromes in humans.
The Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) will develop the new guidelines and Firstline, a Vancouver-based healthcare technology platform, will disseminate the guidelines to health care providers at the point-of-care through a digital platform.
Firstline was initially supported by a co-investment from DIGITAL, Canada’s Global innovation Cluster for digital technologies in 2020 to facilitate the sharing of complex and rapidly changing COVID-19 guidance between healthcare organizations across Canada.
Since then, their innovative platform has evolved into a global tool endorsed by the World Health Organization (WHO) to distribute AMR guidance worldwide.
Leave a Reply